Amir Lakizadeh | Bioinformatics | Best Researcher Award

Dr. Amir Lakizadeh | Bioinformatics | Best Researcher Award

Faculty Staff, University of Qom, Iran

Dr. Amir Lakizadeh is an accomplished researcher and Assistant Professor at the University of Qom, specializing in machine learning and deep learning. As the head of the AI-driven Pharma and Medicine (AIPM) lab, his work spans multimedia, medical diagnostics, and pharmaceutics. With over a decade of academic and industry experience, Dr. Lakizadeh is known for leading cutting-edge projects, mentoring future researchers, and advancing AI applications in drug discovery and healthcare. ๐Ÿš€๐Ÿ“Š

Profile

Scopus

Google Scholar

Orcid

๐ŸŽ“ Education

Dr. Lakizadeh began his academic journey at the University of Tehran, where he earned his Bachelor’s (2001โ€“2005) and Master’s (2005โ€“2007) degrees in Computer Science, focusing on bioinformatics and machine learning. He later completed his Ph.D. in Computer Engineering at Tarbiat Modares University (2011โ€“2016), with research centered on machine learning, computational systems biology, and bioinformatics. ๐ŸŽ“๐Ÿ“š

๐Ÿ’ผ Experience

Since 2008, Dr. Lakizadeh has served as an Assistant Professor at the University of Qom, contributing significantly to research in AI, multimedia, and medical imaging. He has mentored over 70 postgraduate students and spearheaded 30+ research publications. As the current Head of the Computer Engineering and IT Department, he oversees 1000+ students, academic programs, and research initiatives. ๐Ÿ›๏ธ๐Ÿง‘โ€๐Ÿซ

๐Ÿ”ฌ Research Interest

Dr. Lakizadehโ€™s research interests include deep learning, computer vision, digital pathology, drug repurposing, anticancer peptide prediction, and Alzheimerโ€™s detection. He is passionate about creating AI-driven solutions for real-world medical and pharmaceutical challenges. His interdisciplinary work integrates data from biology, medicine, and computer science to deliver impactful innovation. ๐Ÿ’ก๐Ÿง ๐Ÿ’Š

๐Ÿ… Awards

While specific honors aren’t listed, Dr. Lakizadehโ€™s leadership of high-impact AI projects, numerous peer-reviewed publications, and influential role in academia highlight his excellence and recognition in the fields of computer science and bioinformatics. He is a highly respected figure in interdisciplinary AI research. ๐Ÿ†๐Ÿ“˜

๐Ÿ“š Publications

PU-GNN: A Positive-Unlabeled Learning Method for Polypharmacy Side-Effects Detection, International Journal of Intelligent Systems, 2024.
Cited by: Multiple future studies in drug safety prediction.

Drug Repurposing Using Hypergraph Embedding, Journal of Computational Biology, 2024.
Cited by: Studies in computational drug discovery.

GADNN: Graph Attention-based Drug Association Method, Informatics in Medicine Unlocked, 2024.
Cited by: Research in bioinformatics and AI.

Detection of Polypharmacy Side Effects via CNN, Molecular Diversity, 2022.
Cited by: Pharmacological safety frameworks.

Drug-Drug Interaction via GNN, Scientific Reports, 2022.
Cited by: Advanced machine learning in pharma.

ASDvit: Autism Classification using Vision Transformer, Intelligence-Based Medicine, 2025.
Cited by: Pediatric AI diagnostic tools.

Early Diagnosis of Alzheimerโ€™s Disease via ResNet50 and FSBi-LSTM, Informatica, 2025.
Cited by: Neuroscience AI literature.

Face Hallucination via GAN, Journal of Electrical Systems, 2024.
Cited by: Vision-based AI modeling.

Power-Efficient IoT Optimization, Journal of Electrical Systems, 2024.
Cited by: Industrial Internet of Things (IIoT) research.

๐Ÿ† Conclusion

Dr. Amir Lakizadeh demonstrates all the hallmark qualities of a Best Researcher Award recipientโ€”innovation, productivity, leadership, and real-world impact. His work seamlessly bridges foundational AI with urgent healthcare and societal applications. With a few strategic steps toward global engagement and open dissemination, his already impressive profile could set a benchmark for excellence.

Gang LIU | Drug Discovery | Best Researcher Award

Gang LIU | Drug Discovery | Best Researcher Award

Prof Gang LIU, Tsinghua University, China

Prof. Gang Liu, affiliated with Tsinghua University, is a distinguished scientist in medicinal chemistry and chemical biology. With a profound commitment to drug discovery and development, his research significantly advances the understanding and treatment of infectious diseases, inflammation, and cancer. Prof. Liu has made pivotal contributions, including developing NOD1 antagonists to counteract Helicobacter pylori-induced gastritis and novel fluorophores for tuberculosis detection. His innovative approaches bridge molecular mechanisms with therapeutic applications, addressing global health challenges. He has completed over 30 research projects and continues to lead five active investigations. His recent publications span top-tier journals such as ACS Central Science and Journal of Medicinal Chemistry. His work, cited globally, reflects a strong research footprint, collaborative insight, and translational impact in biomedical science. Prof. Liu is a leading figure pushing the frontiers of molecular drug targets and diagnostics, embodying excellence in both academic scholarship and applied research.

Publication Profile

orcid

Education

While exact degrees are not specified in the provided data, Prof. Gang Liuโ€™s advanced role at Tsinghua University suggests an academic foundation rooted in medicinal chemistry, pharmaceutical sciences, or a closely allied field. Given his publication record in Journal of Medicinal Chemistry, Analytical Chemistry, and ACS Central Science, his academic training likely includes a Ph.D. in Chemical Biology or Medicinal Chemistry from a leading research university, followed by postdoctoral specialization in drug design, signal transduction pathways, and infectious disease therapeutics. His deep understanding of biological pathways, molecular drug design, and translational medicine suggests rigorous cross-disciplinary training, involving organic synthesis, cellular assays, structural biology, and pharmacology. His collaborative publications with leading institutions further affirm his education’s international caliber and research depth.

Experience

Prof. Gang Liu serves at Tsinghua University, one of Chinaโ€™s premier research institutions. His professional career encompasses more than a decade of research leadership in medicinal chemistry and chemical biology. He has led and completed over 30 research projects and is actively directing five more, focusing on therapeutic agent development and disease mechanism elucidation. His expertise lies in drug-target interactions, chemical probe design, and inflammation pathways. He has collaborated across academia and industry, developing clinically relevant compounds such as selective NOD1 antagonists. Prof. Liuโ€™s translational research has led to innovation in diagnostics, notably in tuberculosis detection using responsive fluorescent probes. His experience spans mentoring Ph.D. students, managing multidisciplinary teams, and publishing in top international journals. Prof. Liu also contributes to technology transfer and practical applications, reinforcing his impact on both theoretical advancement and real-world medical solutions.

Awards and Honors

Although no specific awards are listed, Prof. Gang Liuโ€™s consistent publication in high-impact journals such as Journal of Medicinal Chemistry, ACS Central Science, and Analytical Chemistry is indicative of academic recognition and peer esteem. His groundbreaking development of a selective NOD1 antagonist for H. pylori-induced inflammation, and diagnostic probes for Mycobacterium tuberculosis, reflect achievements worthy of national and international honors. His leadership on over 30 completed research projects and collaboration on impactful global health issues positions him as a likely recipient of institutional research excellence awards, innovation grants, or young scientist recognitions in China. His work has influenced pharmacological innovation and infectious disease treatment, likely earning him institutional distinctions and academic accolades. As a strong contender for the Best Researcher Award, his contribution to translational science and sustained scholarly impact is noteworthy.

Research Focus

Prof. Gang Liuโ€™s research lies at the intersection of medicinal chemistry, chemical biology, and drug discovery. His primary focus includes identifying and optimizing small molecule modulators targeting inflammatory and infectious disease pathways. Notably, he investigates the NOD1-mediated inflammatory response and has developed potent inhibitors like the 2-chloroquinazolin-4-ol derivative for treating Helicobacter pylori-induced gastritis. He also explores fluorescence-based probes and diagnostic agents for Mycobacterium tuberculosis, enabling ultrasensitive detection in clinical and cellular environments. Prof. Liuโ€™s team applies synthetic chemistry, biological assays, and molecular modeling to optimize lead compounds for therapeutic and diagnostic utility. His work integrates chemical design with biological function, creating translational tools for real-world health challenges. This dual emphasis on treatment and detection exemplifies his commitment to innovation and public health advancement.

Publication Top Notes

VIVEKANAND ASHOK | Medicine and Health Sciences | Best Researcher Award

VIVEKANAND ASHOK | Medicine and Health Sciences | Best Researcher Award

Dr VIVEKANAND ASHOK, Azeezia Health City, India

Dr. Vivekanand Ashok is a dedicated otorhinolaryngologist with a passion for research and surgical excellence. His extensive work spans cochlear implants, otologic surgeries, and head and neck disorders. With numerous high-impact publications in esteemed journals, his research has significantly contributed to advancements in ENT care. His clinical expertise in endoscopic sinus surgery, thyroid disorders, and voice disorders, combined with his academic contributions, makes him a deserving candidate for the Best Researcher Award. His continuous pursuit of innovation in ENT treatments, active participation in conferences, and commitment to medical education further solidify his reputation as an outstanding researcher. ๐Ÿ…๐Ÿ“š๐Ÿ”ฌ

Publication Profile

Orcid

Education

Dr. Vivekanand Ashok ๐ŸŽ“ pursued his MBBS from Azezia Institute of Medical Sciences, Kerala (2014) ๐Ÿฅ๐Ÿ“–, followed by an M.S in ENT from Bangalore Medical College and Research Institute, Karnataka (2020) ๐ŸŽ“๐Ÿฉบ. He further obtained a DNB (ENT) in 2021 ๐Ÿ…๐Ÿ“š and completed a Fellowship in Cochlear Implant Surgery at GMERS Gandhinagar in 2023 ๐ŸŽง๐Ÿ”ฌ. With a strong foundation in otorhinolaryngology, he specializes in ENT surgeries and cochlear implants, demonstrating his dedication to patient care. His rigorous training at top institutions has equipped him with expertise in handling complex ENT cases, establishing him as a leader in the field. ๐Ÿ“˜๐Ÿ’‰๐Ÿ”

Experience

Dr. Vivekanand Ashok is a distinguished ENT specialist with extensive experience in medical education, clinical practice, and research. He served as a Senior Resident at Karnataka Institute of Medical Sciences (2020-2021) ๐Ÿจ๐Ÿ‘จโ€โš•๏ธ and Malabar Cancer Centre, Kerala (2021-2022) ๐ŸŽ—๏ธ๐Ÿฅ, honing his expertise in otolaryngology. Transitioning into academia, he worked as an Assistant Professor at Karuna Medical College, Kerala (2022-2024) ๐ŸŽ“๐Ÿ“–, shaping future medical professionals. Currently, he excels as a Senior Consultant at Co-operative Hospital, Kattappana (2024-2025) ๐Ÿจ๐Ÿฉบ and Azeezia Health City, Palakkad (2025-Present) โš•๏ธ๐Ÿ”ฌ. His dedication to patient care and surgical excellence makes him a respected figure in the field. ๐Ÿ†๐Ÿ‘จโ€โš•๏ธ

Awards & Honors

Dr. Vivekanand Ashokโ€™s dedication to academic excellence and research has earned him prestigious accolades in the field of ENT. He secured 3rd position in the South Zone ENT Quiz (2018) ๐Ÿฅ‰๐Ÿง , demonstrating his deep knowledge and expertise. In 2019, he was a Zonal Round Participant in the South Zone Young Scholar Award ๐ŸŽ–๏ธ๐Ÿ“–, further highlighting his commitment to continuous learning and professional growth. These achievements reflect his passion for advancing medical knowledge and contributing to the field of otolaryngology. Through his dedication to research and education, Dr. Ashok continues to make a significant impact in the medical community. ๐Ÿ†๐Ÿ”ฌ

Research Focus

Dr. Ashok specializes in otorhinolaryngology, cochlear implants, head and neck surgery, and otologic diseases. His research focuses on laryngopharyngeal reflux, rhino-orbital mucormycosis, thyroid carcinomas, and nasal hemangiomas. His work has contributed to improving diagnostic techniques and treatment approaches in ENT disorders. With a passion for innovation, he continues to explore advancements in hearing restoration, sinus surgery, and minimally invasive ENT procedures. ๐ŸŽง๐Ÿ‘‚๐Ÿ“Š

Publication Top Notes